Hence, the CCR2/CCL2 axis has been identified as an interesting target for tumor therapy, and collected data indicate that CCR2/CCL2 signaling plays a relevant role in the tumor-myeloid cell-interaction. The gene discussed is CCL2; the disease is neoplasm.